Pale Fire Capital SE’s Larimar Therapeutics LRMR Stock Holding History

Pale Fire Capital SE’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$131K	Buy	+43,000	New	+$171K	0.01%	68
2026 Q1	–	Sell	-45,218	Closed	-$172K	–	70
2025 Q4	$172K	Hold	45,218	–	–	0.01%	54
2025 Q3	$146K	Buy	45,218 +7,700	+21%	+$28.9K	0.02%	48
2025 Q2	$108K	Hold	37,518	–	–	0.01%	56
2025 Q1	$80.7K	Buy	37,518 +5,209	+16%	+$16.5K	0.01%	51
2024 Q4	$125K	Hold	32,309	–	–	0.03%	40
2024 Q3	$212K	Buy	32,309 +18,017	+126%	+$145K	0.03%	41
2024 Q2	$104K	Buy	+14,292	New	+$109K	0.01%	37
2024 Q1	–	Sell	-12,040	Closed	-$54.8K	–	70
2023 Q4	$54.8K	Hold	12,040	–	–	0.01%	70
2023 Q3	$47.6K	Buy	+12,040	New	+$45.5K	﹤0.01%	68

Other funds holding LRMR

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Pale Fire Capital SE's LRMR Position: Q2 2026 in Review

Pale Fire Capital SE opened a new position in Larimar Therapeutics (LRMR) in Q2 2026: 43,000 shares worth $131K. The stake represents 0.01% of the portfolio and ranks #68 among its holdings. This is a return to the name: Pale Fire Capital SE previously reported a position in LRMR as recently as Q4 2025.

Pale Fire Capital SE first reported a position in LRMR in Q3 2023 and has held it in 10 quarters since. The position peaked at $212K in Q3 2024. 162 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

Pale Fire Capital SE held 43,000 shares of Larimar Therapeutics worth $131K as of Q2 2026.
Larimar Therapeutics was a new Pale Fire Capital SE position in Q2 2026.
Larimar Therapeutics made up 0.01% of Pale Fire Capital SE's portfolio in Q2 2026, its #68 holding.
Pale Fire Capital SE first reported a position in Larimar Therapeutics in Q3 2023 and has held it in 10 quarters since.
Pale Fire Capital SE's Larimar Therapeutics position peaked at $212K in Q3 2024.
162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Pale Fire Capital SE's 13F filing for Q2 2026, filed 13 Aug 2026.